BJU International, 1464-4096

Tidskrift

Fler filtreringsmöjligheter
  1. 2021
  2. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?

    Yasmin Abu-Ghanem, Thomas Powles, Umberto Capitanio, Christian Beisland, Petrus Järvinen, Grant D. Stewart, Eirikur Gudmundsson, Thomas B.L. Lam, Lorenzo Marconi, Sergio Fernandéz-Pello, Harry Nisen, Richard P. Meijer, Alessandro Volpe, Börje Ljungberg, Tobias Klatte, Karim Bensalah, Saeed Dabestani & Axel Bex, 2021 apr 1, I: BJU International.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  3. Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial

    Martin Nyberg, Daniel D. Sjoberg, Sigrid V. Carlsson, Ulrica Wilderäng, Stefan Carlsson, Johan Stranne, Peter Wiklund, Gunnar Steineck, Eva Haglind, Jonas Hugosson & Anders Bjartell, 2021, I: BJU International. 127, 3, s. 361-368

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. 2020
  5. Prospective validation of microseminoprotein-β added to the 4Kscore in predicting high-grade prostate cancer in an international multicentre cohort

    Peter E. Lonergan, Emily A. Vertosick, Melissa Assel, Daniel D. Sjoberg, Alexander Haese, Markus Graefen, Stephen A. Boorjian, George G. Klee, Matthew R. Cooperberg, Kim Pettersson, Erica Routila, Andrew J. Vickers & Hans Lilja, 2020 dec 11, I: BJU International.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  6. Treatment and prognosis of patients with urinary bladder cancer with other primary cancers: a nationwide population-based study in the Bladder Cancer Data Base Sweden (BladderBaSe)

    Firas Aljabery, Fredrik Liedberg, Christel Häggström, Viveka Ströck, Abolfazl Hosseini, Truls Gårdmark, Amir Sherif, Tomas Jerlström, Per Uno Malmström, Oskar Hagberg & Lars Holmberg, 2020 nov, I: BJU International. 126, 5, s. 625-632 8 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  7. Personalised biopsy schedules based on risk of Gleason upgrading for patients with low-risk prostate cancer on active surveillance

    Anirudh Tomer, Daan Nieboer, Monique J. Roobol, Anders Bjartell, Ewout W. Steyerberg & Dimitris Rizopoulos, 2020 jun 12, I: BJU International.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Prostate cancer cells enhance interleukin-15-mediated expansion of NK cells

    Christina Sakellariou, Oussama Elhage, Efthymia Papaevangelou, Giulio Giustarini, Ana M Esteves, Dorota Smolarek, Richard A Smith, Prokar Dasgupta & Christine Galustian, 2020 jan 15, I: BJU International. 125, 1, s. 89-102

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  9. 2019
  10. Oxidative stress and lower urinary tract symptoms: cause or consequence?

    Karl Erik Andersson, 2019, I: BJU International. 123, 5, s. 749-750 2 s.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  11. Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study

    Fredrik Liedberg, Oskar Hagberg, Firas Aljabery, Truls Gårdmark, Abolfazl Hosseini, Staffan Jahnson, Georg Jancke, Tomas Jerlström, Per Uno Malmström, Amir Sherif, Viveka Ströck, Christel Häggström & Lars Holmberg, 2019, I: BJU International. 124, 3, s. 449-456

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. 2018
  13. The Movember Foundation's GAP3 cohort: a profile of the largest global prostate cancer active surveillance database to date

    Sophie M Bruinsma, Liying Zhang, Monique J Roobol, Chris H Bangma, Ewout W Steyerberg, Daan Nieboer, Mieke Van Hemelrijck, Anders Bjartell & Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) consortium, 2018 maj, I: BJU International. 121, 5, s. 737-744

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  14. Familial risks in urolithiasis in the population of Sweden

    Kari Hemminki, Otto Hemminki, Asta Försti, Kristina Sundquist, Jan Sundquist & Xinjun Li, 2018 mar 1, I: BJU International. 121, 3, s. 479-485 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  15. 2017
  16. Long-term third-party assessment of results after continent cutaneous diversion with Lundiana pouch

    Fredrik Liedberg, Sigurdur Gudjonsson, Abai Xu, Pär Ola Bendahl, Thomas Davidsson & Wiking Månsson, 2017, I: BJU International. 120, 4, s. 530-536

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Sentinel node biopsy for prostate cancer: Report from a consensus panel meeting

    Henk G. Van der Poel, Esther M K Wit, Cenk Acar, Nynke S. van den Berg, Fijs W B van Leeuwen, Renato A. Valdes Olmos, Alexander Winter, Friedhelm Wawroschek, Fredrik Liedberg, Steven MacLennan & Thomas Lam, 2017, I: BJU International. 120, 2, s. 204-211

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Socioeconomic factors and penile cancer risk and mortality; a population-based study

    Christian Torbrand, Annette Wigertz, Linda Drevin, Yasin Folkvaljon, Mats Lambe, Ulf Håkansson & Peter Kirrander, 2017, I: BJU International. 119, 2, s. 254-260

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  19. 2016
  20. Oncologic and functional outcomes 1 year after radical prostatectomy for very low risk prostate cancer. Results from the prospective LAPPRO trial.

    Stefan Carlsson, Fredrik Jäderling, Anna Wallerstedt, Tommy Nyberg, Johan Stranne, Thordis Thorsteinsdottir, Sigrid V Carlsson, Anders Bjartell, Jonas Hugosson, Eva Haglind & Gunnar Steineck, 2016 aug, I: BJU International. 118, 2, s. 205-12

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  21. Interpretation of conventional survival analysis and competing risk analysis: An example of hypertension and prostate cancer

    Christel Häggström, Pär Stattin, Tanja Stocks, Hans Garmo, Lars Holmberg & Mieke Van Hemelrijck, 2016 mar 31, I: BJU International. 118, 6, s. 850–852

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  22. The Accuracy of Prostate Biopsies for Predicting Gleason Score in Radical Prostatectomy Specimens. Nationwide trends 2000-2012.

    Daniela Danneman, Linda Drevin, Brett Delahunt, Hemamali Samaratunga, David Robinson, Ola Bratt, Stacy Loeb, Pär Stattin & Lars Egevad, 2016, I: BJU International.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  23. 2015
  24. Development of a standardised training curriculum for robotic surgery: a consensus statement from an international multidisciplinary group of experts

    Kamran Ahmed, Reenam Khan, Alexandre Mottrie, Catherine Lovegrove, Ronny Abaza, Rajesh Ahlawat, Thomas Ahlering, Göran Ahlgren, Walter Artibani, Eric Barret, Xavier Cathelineau, Ben Challacombe, Patrick Coloby, Muhammad S. Khan, Jacques Hubert, Maurice Stephan Michel, Francesco Montorsi, Declan Murphy, Joan Palou, Vipul Patel & 19 andra, Pierre-Thierry Piechaud, Hendrik Van Poppel, Pascal Rischmann, Rafael Sanchez-Salas, Stefan Siemer, Michael Stoeckle, Jens-Uwe Stolzenburg, Jean-Etienne Terrier, Joachim W. Thueroff, Christophe Vaessen, Henk G. Van der Poel, Ben Van Cleynenbreugel, Alessandro Volpe, Christian Wagner, Peter Wiklund, Timothy Wilson, Manfred Wirth, Joern Witt & Prokar Dasgupta, 2015, I: BJU International. 116, 1, s. 93-101

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Upper Limit of Cancer Extent on Biopsy Defining Very Low Risk Prostate Cancer.

    Ola Bratt, Yasin Folkvaljon, Stacy Loeb, Laurence Klotz, Lars Egevad & Pär Stattin, 2015, I: BJU International. 116, 2, s. 213-219

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. URB937, a peripherally-restricted inhibitor for fatty acid amide hydrolase, reduces prostaglandin E2 -induced bladder overactivity and hyperactivity of bladder mechano-afferent nerve fibers in rats.

    Naoki Aizawa, Giorgio Gandaglia, Petter Hedlund, Tetsuya Fujimura, Hiroshi Fukuhara, Francesco Montorsi, Yukio Homma & Yasuhiko Igawa, 2015, I: BJU International.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. 2014
  28. Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?

    Johannes M. Wolff, Per-Anders Abrahamsson, Jacques Irani & Fernando Calais da Silva, 2014, I: BJU International. 114, 4, s. 476-483

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  29. 2013
  30. Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?

    Sigrid V. Carlsson, Mari T. Peltola, Daniel Sjoberg, Fritz H. Schroder, Jonas Hugosson, Kim Pettersson, Peter T. Scardino, Andrew J. Vickers, Hans Lilja & Monique J. Roobol, 2013, I: BJU International. 112, 5, s. 602-609

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  31. Treatment with curative intent and survival in men with high-risk prostate cancer. A population-based study of 11 380 men with serum PSA level 20-100 ng/mL.

    Sam Ladjevardi, Anders Berglund, Eberhard Varenhorst, Ola Bratt, Anders Widmark & Gabriel Sandblom, 2013, I: BJU International. 111, 3, s. 381-388

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  32. 2012
  33. Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.

    Henrik Kjölhede, Göran Ahlgren, Helen Almquist, Fredrik Liedberg, Kerstin Lyttkens, Tomas G Ohlsson & Ola Bratt, 2012, I: BJU International. 110, 10, s. 1501-1506

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  34. Testosterone in prostate cancer: the Bethesda consensus.

    Bob Djavan, James Eastham, Leonard Gomella, Bertrand Tombal, Samir Taneja, Seyed Saeid Dianat, Amir Kazzazi, Neal Shore, Per-Anders Abrahamsson, Philippa Cheetham, Judd Moul, Herbert Lepor & E David Crawford, 2012, I: BJU International. 110, 3, s. 344-352

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  35. 2011
  36. Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcome.

    Agnes Marije Hoogland, Anna K Dahlman, Kees J Vissers, Tineke Wolters, Fritz Schröder, Monique Roobol, Anders Bjartell & Geert J L H van Leenders, 2011, I: BJU International. 108, 8, s. 1356-1362

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  37. The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).

    Sigurdur Gudjonsson, Mats Bläckberg, Gunilla Chebil, Staffan Jahnson, Hans Olsson, Pär-Ola Bendahl, Wiking Månsson & Fredrik Liedberg, 2011, I: BJU International.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  38. 2010
  39. Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized study

    Anders Mattiasson, Alberto Masala, Richard Morton & John Bolodeoku, 2010, I: BJU International. 105, 8, s. 1126-1135

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  40. 2009
  41. Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study

    Fritz H. Schroeder, Chris H. Bangma, Johannes M. Wolff, Antonio Alcaraz, Francesco Montorsi, Pierre Mongiat-Artus, Per-Anders Abrahamsson, Tom A. McNicholas, Ramiro S. Castro & Indrani M. Nandy, 2009, I: BJU International. 103, 5, s. 590-596

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  42. Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer

    Sameer Jhavar, Daniel Brewer, Sandra Edwards, Zsofia Kote-Jarai, Gerhardt Attard, Jeremy Clark, Penny Flohr, Timothy Christmas, Alan Thompson, Matthew Parker, Christopher Shepherd, Ulf-Hakan Stenman, Tania Marchbank, Raymond J. Playford, Christopher Woodhouse, Christopher Ogden, Cyril Fisher, Gyula Kovacs, Cathy Corbishley, Charles Jameson & 5 andra, Andy Norman, Johann De-Bono, Anders Bjartell, Rosalind Eeles & Colin S. Cooper, 2009, I: BJU International. 103, 9, s. 1256-1269

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  43. Optimal management of metastatic renal cell carcinoma: an algorithm for treatment.

    Joaquim Bellmunt, Per Flodgren, Jan Roigas & Stéphane Oudard, 2009, I: BJU International. 104, s. 10-18

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  44. Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates

    Fred Saad, Per-Anders Abrahamsson & Kurt Miller, 2009, I: BJU International. 104, 11, s. 1573-1579

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  45. Receptor-induced phasic activity of newborn mouse bladders is inhibited by protein kinase C and involves T-type Ca channels.

    Mari Ekman, Karl-Erik Andersson & Anders Arner, 2009, I: BJU International. 104, 5, s. 690-697

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  46. Signal transduction pathways of muscarinic receptor mediated activation in the newborn and adult mouse urinary bladder.

    Mari Ekman, Karl-Erik Andersson & Anders Arner, 2009, I: BJU International. 103, s. 90-97

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  47. THE CONTINUING ROLE OF PROSTATE-SPECIFIC ANTIGEN AS A MARKER FOR LOCALIZED PROSTATE CANCER: 'DO NOT THROW THE BABY OUT WITH THE BATH WATER'

    Ben J Challacombe, Declan Murphy, Hans Lilja, Andrew J Vickers & Anthony J Costello, 2009, I: BJU International. 104, s. 1553-1554

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  48. The developing role of hormonal therapy in the treatment of prostate cancer.

    Per-Anders Abrahamsson, 2009, I: BJU International. 103 Suppl 2, s. 41275

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  49. Treatment of prostate cancer with hormonal therapy in Europe

    Kurt Miller, John Anderson & Per-Anders Abrahamsson, 2009, I: BJU International. 103, s. 41311

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  50. Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder.

    Viktoria Werkström, Petter Hedlund, Tack Lee & Karl-Erik Andersson, 2009, I: BJU International. 104, s. 1740-1745

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  51. 2008
  52. Incontinent urinary diversion.

    Sigurdur Gudjonsson, Thomas Davidsson & Wiking Månsson, 2008, I: BJU International. 102, 9 Pt B, s. 1320-1325

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  53. Management of advanced prostate cancer: can we improve on androgen deprivation therapy?

    J Anderson, Per-Anders Abrahamsson, David Crawford, Kurt Miller & Bertrand Tombal, 2008, I: BJU International. 101, s. 1497-1501

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  54. Non-genomic effects of androgens on isolated human vascular and nonvascular penile erectile tissue

    Eginhard Waldkirch, Stefan Ucker, Dirk Schultheiss, Ulrike Geismar, Carola Bruns, Friedemann Scheller, Udo Jonas, Armin J. Becker, Christian G. Stief & Petter Hedlund, 2008, I: BJU International. 101, 1, s. 71-74

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  55. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.

    Peter Ney, Raj Kumar Pandita, Donald T Newgreen, Alexander Breidenbach, Thomas Stöhr & Karl-Erik Andersson, 2008, I: BJU International. 101, s. 1036-1042

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  56. 2007
  57. Inhibition of the epidermal growth factor receptor in bladder cancer cells treated with the DNA-damaging drug etoposide markedly increases apoptosis

    Mathias Munk, Ashfaque Ahmed Memon, Ebba Nexo & Boe Sandahl Sorensen, 2007 jan, I: BJU International. 99, 1, s. 196-201

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  58. Active surveillance vs radical prostatectomy.

    Per-Anders Abrahamsson, 2007, I: BJU International. 100, s 2, s. 26-28

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  59. Dysregulation of cGMP-dependent protein kinase 1 (PKG-1) impairs erectile function in diabetic rats: influence of in vivo gene therapy of PKG1 alpha

    Trinity J. Bivalacqua, Muammer Kendirci, Hunter C. Champion, Wayne J. G. Hellstrom, Karl-Erik Andersson & Petter Hedlund, 2007, I: BJU International. 99, 6, s. 1488-1494

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  60. What should a urologist know about hereditary predisposition to prostate cancer?

    Ola Bratt, 2007, I: BJU International. 99, 4, s. 743-747

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

Föregående 1 2 Nästa